Celldex Therapeutics, Inc. — Director's Dealing 2010

Sep 22, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2010-09-22

Reporting Person: PAREKH RAJESH R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-09-22	Common Stock	A	2000	—	Acquired	2000	Direct

Footnotes

F1: On September 22, 2010, the Company awarded 2,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan, subject to time-based forfeiture restrictions.